|
[1]
|
Asiatic acid as a leading structure for derivatives combining sub-nanomolar cytotoxicity, high selectivity, and the ability to overcome drug resistance in human preclinical tumor models
European Journal of Medicinal Chemistry,
2023
DOI:10.1016/j.ejmech.2023.115189
|
|
|
|
|
[2]
|
Synthesis and Biological Evaluation of α-Tocopherol Derivatives as Potential Anticancer Agents
Processes,
2023
DOI:10.3390/pr11061860
|
|
|
|
|
[3]
|
Asiatic acid as a leading structure for derivatives combining sub-nanomolar cytotoxicity, high selectivity, and the ability to overcome drug resistance in human preclinical tumor models
European Journal of Medicinal Chemistry,
2023
DOI:10.1016/j.ejmech.2023.115189
|
|
|
|
|
[4]
|
A peptide-derived strategy for specifically targeting the mitochondria and ER of cancer cells: a new approach in fighting cancer
Chemical Science,
2022
DOI:10.1039/D2SC01934E
|
|
|
|
|
[5]
|
Type and position of linkage govern the cytotoxicity of oleanolic acid rhodamine B hybrids
Steroids,
2021
DOI:10.1016/j.steroids.2021.108876
|
|
|
|
|
[6]
|
Cytotoxic triterpenoid–safirinium conjugates target the endoplasmic reticulum
European Journal of Medicinal Chemistry,
2021
DOI:10.1016/j.ejmech.2020.112920
|
|
|
|
|
[7]
|
Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism
Dalton Transactions,
2021
DOI:10.1039/D0DT03194A
|
|
|
|
|
[8]
|
Gold(I) Complexes Bearing Alkylated 1,3,5-Triaza-7-phosphaadamantane Ligands as Thermoresponsive Anticancer Agents in Human Colon Cells
Biomedicines,
2021
DOI:10.3390/biomedicines9121848
|
|
|
|
|
[9]
|
Type and position of linkage govern the cytotoxicity of oleanolic acid rhodamine B hybrids
Steroids,
2021
DOI:10.1016/j.steroids.2021.108876
|
|
|
|
|
[10]
|
TPP-based mitocans: a potent strategy for anticancer drug design
RSC Medicinal Chemistry,
2020
DOI:10.1039/C9MD00572B
|
|
|
|
|
[11]
|
Targeting Mitochondria through the Use of Mitocans as Emerging Anticancer Agents
Current Medicinal Chemistry,
2020
DOI:10.2174/0929867326666190712150638
|
|
|
|
|
[12]
|
Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects
Molecular Pharmaceutics,
2020
DOI:10.1021/acs.molpharmaceut.0c00417
|
|
|
|
|
[13]
|
Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects
Molecular Pharmaceutics,
2020
DOI:10.1021/acs.molpharmaceut.0c00417
|
|
|
|
|
[14]
|
An X-ray and Natural Bond Orbital (NBO) structural study of α-tocopheryl and 2,2,5,7,8-pentamethylchroman-6-yl succinates
Journal of Saudi Chemical Society,
2019
DOI:10.1016/j.jscs.2018.08.010
|
|
|
|
|
[15]
|
Mitochondria-Targeting Anticancer Metal Complexes
Current Medicinal Chemistry,
2019
DOI:10.2174/0929867325666180307112029
|
|
|
|
|
[16]
|
Mitochondria-localizing BODIPY–copper(ii) conjugates for cellular imaging and photo-activated cytotoxicity forming singlet oxygen
Dalton Transactions,
2018
DOI:10.1039/C8DT00255J
|
|
|
|
|
[17]
|
Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis
European Journal of Medicinal Chemistry,
2018
DOI:10.1016/j.ejmech.2018.04.031
|
|
|
|
|
[18]
|
Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations
European Journal of Medicinal Chemistry,
2017
DOI:10.1016/j.ejmech.2016.12.040
|
|
|
|